Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
603896 Zhejiang Shouxiangu Pharmaceutical
- 23.72
- +0.70+3.04%
Not Open Dec 12 15:00 CST
4.70BMarket Cap20.12P/E (TTM)
23.72High22.91Low58.95KlotVolume23.15Open23.02Pre Close138.03MTurnover2.97%Turnover Ratio18.47P/E (Static)198.24MShares32.4952wk High2.17P/B4.70BFloat Cap18.4952wk Low25.32Limit Up198.24MShs Float57.84Historical High20.72Limit Down3.52%Amplitude8.76Historical Low0.39Dividend TTM23.41Avg Price22.98KlotAsk1.64%Div YieldTTM100Lot Size33.83KlotBid
Zhejiang Shouxiangu Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -13.01%472.04M | -5.09%352.59M | 7.15%220.9M | -5.39%784.35M | 6.89%542.63M | 6.28%371.49M | 1.20%206.16M | 8.07%829.07M | 5.82%507.64M | 10.09%349.53M |
| Operating revenue | -13.01%472.04M | -5.09%352.59M | 7.15%220.9M | -5.39%784.35M | 6.89%542.63M | 6.28%371.49M | 1.20%206.16M | 8.07%829.07M | 5.82%507.64M | 10.09%349.53M |
| Other operating revenue | ---- | -8.68%6.13M | ---- | 22.89%14.01M | ---- | 43.59%6.72M | ---- | 59.49%11.4M | ---- | 47.25%4.68M |
| Total operating cost | -9.38%387.3M | -7.57%275.47M | 1.23%153.63M | -0.43%574.86M | 6.79%427.39M | 3.99%298.02M | 1.09%151.77M | 1.56%577.34M | -1.03%400.22M | 4.55%286.59M |
| Operating cost | -2.67%91.94M | -1.14%65.94M | 11.17%37.74M | 4.89%135.53M | 23.61%94.46M | 27.10%66.7M | 14.69%33.95M | 2.24%129.21M | -7.96%76.42M | -4.69%52.48M |
| Operating tax surcharges | 15.25%5.99M | 23.33%4.31M | 53.66%3.16M | 24.03%8.91M | 13.67%5.2M | -1.67%3.5M | 23.52%2.06M | -8.06%7.18M | -20.74%4.57M | -15.10%3.56M |
| Operating expense | -8.25%211.63M | -5.44%156.09M | 2.40%90.88M | -0.81%316.79M | -2.46%230.67M | -4.29%165.07M | -6.76%88.75M | -0.12%319.37M | -0.30%236.48M | 8.16%172.47M |
| Administration expense | -7.32%63.05M | -1.03%41.78M | 5.10%21.06M | 1.39%86.99M | 18.60%68.02M | 18.21%42.21M | 14.36%20.04M | 10.81%85.8M | 1.99%57.36M | -1.73%35.71M |
| Financial expense | -58.39%-17.12M | -163.13%-15.81M | -138.66%-10.64M | -91.24%-23.04M | 13.90%-10.81M | -31.83%-6.01M | 4.18%-4.46M | 12.13%-12.05M | 2.98%-12.55M | -73.41%-4.56M |
| -Interest expense (Financial expense) | -55.56%11.63M | -57.50%7.94M | -50.28%4.69M | 89.62%24.7M | 262.17%26.18M | 377.57%18.67M | 398.90%9.44M | 28.10%13.03M | -13.37%7.23M | -38.24%3.91M |
| -Interest Income (Financial expense) | 22.17%-28.97M | 3.73%-23.91M | -27.75%-17.89M | -88.97%-48.09M | -85.49%-37.23M | -188.05%-24.83M | -111.06%-14M | -5.31%-25.45M | 6.64%-20.07M | 5.33%-8.62M |
| Research and development | -20.17%31.81M | -12.79%23.17M | -0.03%11.43M | 3.89%49.68M | 5.03%39.85M | -1.38%26.56M | 5.67%11.43M | -5.90%47.82M | 8.08%37.94M | 24.16%26.93M |
| Credit Impairment Loss | -138.75%-223.29K | -137.20%-509.76K | -343.48%-3.12M | 159.92%1.13M | -46.23%576.16K | 3.15%1.37M | 576.52%1.28M | -78.54%-1.88M | 98.71%1.07M | 7.19%1.33M |
| Adjustment items of total operating cost | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | 50.27%34.03M | 59.02%23.49M | 56.73%9.42M | 55.22%45.24M | -6.63%22.65M | -25.88%14.77M | 6.78%6.01M | 242.75%29.15M | 59.02%24.26M | 53.15%19.93M |
| Fair value change income | 699.83%2.17M | ---- | ---- | 121.54%271.43K | 121.54%271.43K | 121.54%271.43K | ---- | 89.78%-1.26M | ---1.26M | ---1.26M |
| Invest income | -8.99%3.12M | -26.67%2.47M | -84.91%90.9K | -18.92%3.68M | -10.44%3.42M | -5.56%3.37M | -33.29%602.25K | -33.58%4.54M | -10.56%3.82M | -11.21%3.57M |
| -Including: Investment income associates | -167.71%-79.72K | -311.60%-130.43K | 164.42%90.9K | 245.95%375.71K | 142.43%117.75K | 131.56%61.64K | -227.55%-141.09K | 74.62%-257.43K | 54.73%-277.49K | 50.12%-195.31K |
| Asset deal income | 726,469.56%8.6M | 726,271.92%8.6M | --5.68M | 138.26%172.51K | -108.95%-1.18K | -108.95%-1.18K | ---- | 110.36%72.4K | -62.70%13.23K | -64.86%13.23K |
| Other revenue | 10.83%20.37M | 32.44%12.93M | 63.95%6.77M | 44.49%39.99M | -10.83%18.38M | -40.03%9.77M | -17.11%4.13M | 84.30%27.67M | 98.06%20.61M | 110.88%16.29M |
| Operating profit | -13.86%118.78M | 14.01%100.61M | 26.98%76.7M | -9.31%254.72M | 4.71%137.9M | 6.48%88.24M | 2.01%60.4M | 35.59%280.88M | 45.34%131.69M | 46.95%82.87M |
| Add:Non operating Income | -83.90%405.59K | -85.59%360.85K | -90.14%244.42K | 507.13%2.6M | 573.27%2.52M | 6,858.44%2.5M | 20,937.07%2.48M | 225.29%428.21K | 284.92%374.15K | -54.49%35.98K |
| Less:Non operating expense | -17.76%612.38K | -66.78%130.22K | -63.74%67.25K | -27.83%2.41M | -48.06%744.62K | 88.00%391.96K | 503.22%185.45K | -46.32%3.34M | -56.00%1.43M | -88.84%208.49K |
| Total profit | -15.11%118.57M | 11.60%100.84M | 22.61%76.87M | -8.29%254.91M | 6.92%139.67M | 9.25%90.35M | 5.92%62.7M | 38.25%277.97M | 49.38%130.63M | 51.44%82.7M |
| Less:Income tax cost | -132.42%-100.11K | -131.47%-37.06K | -402.30%-256.56K | -4.79%430.87K | -36.78%308.73K | -77.44%117.76K | 65.55%84.87K | -39.60%452.57K | -37.52%488.31K | 234.94%521.98K |
| Net profit | -14.85%118.67M | 11.79%100.87M | 23.19%77.13M | -8.30%254.48M | 7.09%139.36M | 9.80%90.24M | 5.86%62.61M | 38.54%277.51M | 50.16%130.14M | 49.43%82.18M |
| Net profit from continuing operation | -14.85%118.67M | 11.79%100.87M | 23.19%77.13M | -8.30%254.48M | 7.09%139.36M | 9.80%90.24M | 5.86%62.61M | 38.54%277.51M | 50.16%130.14M | 49.43%82.18M |
| Less:Minority Profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.58%-270.07K | 100.98%3.78K | --162.71K |
| Net profit of parent company owners | -14.85%118.67M | 11.79%100.87M | 23.19%77.13M | -8.39%254.48M | 7.09%139.36M | 10.02%90.24M | 6.13%62.61M | 38.32%277.78M | 49.49%130.14M | 49.13%82.02M |
| Earning per share | ||||||||||
| Basic earning per share | -15.49%0.6 | 10.87%0.51 | 21.88%0.39 | -9.09%1.3 | 5.97%0.71 | 9.52%0.46 | 6.67%0.32 | 36.19%1.43 | 48.89%0.67 | 44.83%0.42 |
| Diluted earning per share | -15.49%0.6 | 10.87%0.51 | 21.88%0.39 | -9.09%1.3 | 5.97%0.71 | 9.52%0.46 | 6.67%0.32 | 36.19%1.43 | 48.89%0.67 | 44.83%0.42 |
| Other composite income | 256.97%19.23M | 133.22%12.9M | 87.02%10.7M | 247.16%2.99M | 270.86%5.39M | 19.38%5.53M | 17.39%5.72M | -4.33%-2.03M | -1,720.91%-3.15M | 42.31%4.63M |
| Other composite income of parent company owners | 256.97%19.23M | 133.22%12.9M | 87.02%10.7M | 247.16%2.99M | 270.86%5.39M | 19.38%5.53M | 17.39%5.72M | -4.33%-2.03M | -1,720.91%-3.15M | 42.31%4.63M |
| Total composite income | -4.73%137.9M | 18.80%113.78M | 28.54%87.83M | -6.54%257.47M | 13.99%144.75M | 10.32%95.77M | 6.74%68.33M | 38.88%275.48M | 46.19%126.99M | 49.03%86.81M |
| Total composite income of parent company owners | -4.73%137.9M | 18.80%113.78M | 28.54%87.83M | -6.63%257.47M | 13.99%144.75M | 10.52%95.77M | 6.99%68.33M | 38.65%275.75M | 45.54%126.98M | 48.75%86.65M |
| Total composite income of minority owners | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 47.58%-270.07K | 100.98%3.78K | --162.71K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
